Mylan down 4% premarket in sympathy with Teva; Q2 earnings August 9

|About: Mylan N.V. (MYL)|By:, SA News Editor

Mylan N.V. (NASDAQ:MYL) is joined at the hip with Teva. Shares are down 4% premarket on robust volume, matching Teva's decline. Q2 earnings are on tap for Wednesday, August 9 before the open.

Previously: Teva's travails bearish for Mylan - RBC (Aug. 4)

Subscribe for full text news in your inbox